Skip to main content

Susceptibility of the Bacteroides fragilis group in the United States in 1981.

Publication ,  Journal Article
Tally, FP; Cuchural, GJ; Jacobus, NV; Gorbach, SL; Aldridge, KE; Cleary, TJ; Finegold, SM; Hill, GB; Iannini, PB; McCloskey, RV; O'Keefe, JP ...
Published in: Antimicrob Agents Chemother
April 1983

The minimal inhibitory concentrations of nine antimicrobial agents was determined for over 750 clinical isolates of the Bacteroides fragilis group of anaerobic bacteria collected from nine centers in the United States during 1981. High resistance rates were documented for cefoperazone, cefotaxime, and tetracycline. Cefoxitin had the best activity of the beta-lactam antibiotics, whereas moxalactam and piperacillin had good activities. The resistance rate for clindamycin was 6%. There were no metronidazole- or chloramphenicol-resistant isolates encountered. There were significant differences in susceptibility among the various species of the B. fragilis group, particularly with moxalactam, cefoxitin, and clindamycin. Clustering of clindamycin-, piperacillin-, and cefoxitin-resistant isolates was observed at different hospitals. The variability of resistance rates with the beta-lactam antibiotics and clindamycin indicates that susceptibility testing of significant clinical isolates should be performed to define local resistance patterns.

Duke Scholars

Published In

Antimicrob Agents Chemother

DOI

ISSN

0066-4804

Publication Date

April 1983

Volume

23

Issue

4

Start / End Page

536 / 540

Location

United States

Related Subject Headings

  • United States
  • Time Factors
  • Microbiology
  • Microbial Sensitivity Tests
  • Drug Resistance, Microbial
  • Bacteroides fragilis
  • Anti-Bacterial Agents
  • 3214 Pharmacology and pharmaceutical sciences
  • 3207 Medical microbiology
  • 3107 Microbiology
 

Citation

APA
Chicago
ICMJE
MLA
NLM
Tally, F. P., Cuchural, G. J., Jacobus, N. V., Gorbach, S. L., Aldridge, K. E., Cleary, T. J., … Pierson, C. L. (1983). Susceptibility of the Bacteroides fragilis group in the United States in 1981. Antimicrob Agents Chemother, 23(4), 536–540. https://doi.org/10.1128/AAC.23.4.536
Tally, F. P., G. J. Cuchural, N. V. Jacobus, S. L. Gorbach, K. E. Aldridge, T. J. Cleary, S. M. Finegold, et al. “Susceptibility of the Bacteroides fragilis group in the United States in 1981.Antimicrob Agents Chemother 23, no. 4 (April 1983): 536–40. https://doi.org/10.1128/AAC.23.4.536.
Tally FP, Cuchural GJ, Jacobus NV, Gorbach SL, Aldridge KE, Cleary TJ, et al. Susceptibility of the Bacteroides fragilis group in the United States in 1981. Antimicrob Agents Chemother. 1983 Apr;23(4):536–40.
Tally, F. P., et al. “Susceptibility of the Bacteroides fragilis group in the United States in 1981.Antimicrob Agents Chemother, vol. 23, no. 4, Apr. 1983, pp. 536–40. Pubmed, doi:10.1128/AAC.23.4.536.
Tally FP, Cuchural GJ, Jacobus NV, Gorbach SL, Aldridge KE, Cleary TJ, Finegold SM, Hill GB, Iannini PB, McCloskey RV, O’Keefe JP, Pierson CL. Susceptibility of the Bacteroides fragilis group in the United States in 1981. Antimicrob Agents Chemother. 1983 Apr;23(4):536–540.

Published In

Antimicrob Agents Chemother

DOI

ISSN

0066-4804

Publication Date

April 1983

Volume

23

Issue

4

Start / End Page

536 / 540

Location

United States

Related Subject Headings

  • United States
  • Time Factors
  • Microbiology
  • Microbial Sensitivity Tests
  • Drug Resistance, Microbial
  • Bacteroides fragilis
  • Anti-Bacterial Agents
  • 3214 Pharmacology and pharmaceutical sciences
  • 3207 Medical microbiology
  • 3107 Microbiology